naftopidil has been researched along with Urethral Obstruction in 4 studies
Urethral Obstruction: Partial or complete blockage in any part of the URETHRA that can lead to difficulty or inability to empty the URINARY BLADDER. It is characterized by an enlarged, often damaged, bladder with frequent urges to void.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Thirty-two patients with voiding dysfunction attributable to symptomatic benign prostatic hyperplasia were treated with naftopidil, an alpha 1-blocker, at doses of 25-75 mg/day for 4-6 weeks." | 9.07 | Effect of naftopidil on urethral obstruction in benign prostatic hyperplasia: assessment by urodynamic studies. ( Akimoto, S; Nagashima, K; Shimazaki, J; Tojo, M; Yamanishi, T; Yasuda, K, 1994) |
| "Thirty-two patients with voiding dysfunction attributable to symptomatic benign prostatic hyperplasia were treated with naftopidil, an alpha 1-blocker, at doses of 25-75 mg/day for 4-6 weeks." | 5.07 | Effect of naftopidil on urethral obstruction in benign prostatic hyperplasia: assessment by urodynamic studies. ( Akimoto, S; Nagashima, K; Shimazaki, J; Tojo, M; Yamanishi, T; Yasuda, K, 1994) |
| " Recently, three drugs (tamsulosin, naftopidil, and silodosin) have been developed in Japan for the treatment of urinary obstruction in patients with benign prostatic hyperplasia." | 4.83 | [Alpha1-adrenoceptor subtypes and alpha1-adrenoceptor antagonists]. ( Morishima, S; Muramatsu, I; Suzuki, F; Tanaka, T; Yamamoto, H, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Muramatsu, I | 1 |
| Suzuki, F | 1 |
| Tanaka, T | 1 |
| Yamamoto, H | 1 |
| Morishima, S | 1 |
| Kawabe, K | 1 |
| Tatemichi, S | 1 |
| Tomiyama, Y | 1 |
| Maruyama, I | 1 |
| Kobayashi, S | 1 |
| Kobayashi, K | 1 |
| Maezawa, A | 1 |
| Kobayashi, M | 1 |
| Yamazaki, Y | 1 |
| Shibata, N | 1 |
| Yasuda, K | 1 |
| Yamanishi, T | 1 |
| Tojo, M | 1 |
| Nagashima, K | 1 |
| Akimoto, S | 1 |
| Shimazaki, J | 1 |
2 reviews available for naftopidil and Urethral Obstruction
| Article | Year |
|---|---|
[Alpha1-adrenoceptor subtypes and alpha1-adrenoceptor antagonists].
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Amino Acid Sequence; Animals; | 2006 |
[Latest frontiers in pharmacotherapy for benign prostatic hyperplasia].
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Drug Design; Drug Therapy, Co | 2006 |
1 trial available for naftopidil and Urethral Obstruction
| Article | Year |
|---|---|
Effect of naftopidil on urethral obstruction in benign prostatic hyperplasia: assessment by urodynamic studies.
Topics: Adrenergic alpha-Antagonists; Aged; Humans; Male; Middle Aged; Naphthalenes; Piperazines; Prostatic | 1994 |
1 other study available for naftopidil and Urethral Obstruction
| Article | Year |
|---|---|
Uroselectivity in male dogs of silodosin (KMD-3213), a novel drug for the obstructive component of benign prostatic hyperplasia.
Topics: Adrenergic alpha-1 Receptor Agonists; Adrenergic alpha-Antagonists; Animals; Blood Pressure; Carotid | 2006 |